In Brief: Laser Industries
This article was originally published in The Gray Sheet
Executive Summary
Laser Industries: Receives FDA clearance for the company's minimally invasive Sharplan u Sight system, an ultrasound system designed to assist surgeons "in detecting pathologies such as tumors inside the liver or colon, or the presence of ductal stones during laparoscopic surgery," the Israel-based company says. The product line inclues the u Sight laparoscopic ultrasound system, the i Sight computerized endoscopic video camera, and the bi Sight module, which presents a combined visual and ultrasound image of the surgical site on a single monitor screen. Laser Industries' worldwide distribution network will market the system...
You may also be interested in...
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.